Doximity faces flat growth, competitive pressure, and overvaluation, making it a potential short with a $45 target. Click ...

Doximity’s stock fell sharply in aftermarket trading, dropping 23.44% to $44.75. Doximity demonstrated robust financial performance in Q4 FY2025, with revenue growing 17% year-over-year to $138 ...

Doximity DOCS reported fourth-quarter fiscal ... shares of DOCS plunged 20.7% during after-hours trading on May 15. The stock fell 9.5% year to date compared with a 6.2% decline in the industry.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

In light of the recent options history for Doximity, it's now appropriate to focus on the company itself. We aim to explore its current performance ... suggest the stock is currently may be ...

Doximity DOCS reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of 38 cents, which beat the Zacks ...

Doximity's Q4 performance likely witnessed strong product ... holding steady at $58. However, the stock is beating the S&P 500’s 6.2% decline during that period. Doximity (DOCS) concluded ...

Doximity saw increased retail buzz on Thursday following its fourth-quarter (Q4) earnings report, which displayed strong ...

UnitedHealth stock is rising after declining for eight consecutive sessions, Applied Materials issues a disappointing revenue outlook, and Doximity ... has affected the performance of the Dow ...

Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.